{
  "pmid": "20587587",
  "uid": "20587587",
  "title": "Effects of medical therapies on retinopathy progression in type 2 diabetes.",
  "abstract": "BACKGROUND: We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data suggest that these systemic factors may be important in the development and progression of diabetic retinopathy. METHODS: In a randomized trial, we enrolled 10,251 participants with type 2 diabetes who were at high risk for cardiovascular disease to receive either intensive or standard treatment for glycemia (target glycated hemoglobin level, <6.0% or 7.0 to 7.9%, respectively) and also for dyslipidemia (160 mg daily of fenofibrate plus simvastatin or placebo plus simvastatin) or for systolic blood-pressure control (target, <120 or <140 mm Hg). A subgroup of 2856 participants was evaluated for the effects of these interventions at 4 years on the progression of diabetic retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study Severity Scale (as assessed from seven-field stereoscopic fundus photographs, with 17 possible steps and a higher number of steps indicating greater severity) or the development of diabetic retinopathy necessitating laser photocoagulation or vitrectomy. RESULTS: At 4 years, the rates of progression of diabetic retinopathy were 7.3% with intensive glycemia treatment, versus 10.4% with standard therapy (adjusted odds ratio, 0.67; 95% confidence interval [CI], 0.51 to 0.87; P=0.003); 6.5% with fenofibrate for intensive dyslipidemia therapy, versus 10.2% with placebo (adjusted odds ratio, 0.60; 95% CI, 0.42 to 0.87; P=0.006); and 10.4% with intensive blood-pressure therapy, versus 8.8% with standard therapy (adjusted odds ratio, 1.23; 95% CI, 0.84 to 1.79; P=0.29). CONCLUSIONS: Intensive glycemic control and intensive combination treatment of dyslipidemia, but not intensive blood-pressure control, reduced the rate of progression of diabetic retinopathy. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov numbers, NCT00000620 for the ACCORD study and NCT00542178 for the ACCORD Eye study.)",
  "authors": [
    {
      "affiliations": []
    },
    {
      "affiliations": []
    },
    {
      "last_name": "Chew",
      "fore_name": "Emily Y",
      "initials": "EY",
      "name": "Emily Y Chew",
      "affiliations": []
    },
    {
      "last_name": "Ambrosius",
      "fore_name": "Walter T",
      "initials": "WT",
      "name": "Walter T Ambrosius",
      "affiliations": []
    },
    {
      "last_name": "Davis",
      "fore_name": "Matthew D",
      "initials": "MD",
      "name": "Matthew D Davis",
      "affiliations": []
    },
    {
      "last_name": "Danis",
      "fore_name": "Ronald P",
      "initials": "RP",
      "name": "Ronald P Danis",
      "affiliations": []
    },
    {
      "last_name": "Gangaputra",
      "fore_name": "Sapna",
      "initials": "S",
      "name": "Sapna Gangaputra",
      "affiliations": []
    },
    {
      "last_name": "Greven",
      "fore_name": "Craig M",
      "initials": "CM",
      "name": "Craig M Greven",
      "affiliations": []
    },
    {
      "last_name": "Hubbard",
      "fore_name": "Larry",
      "initials": "L",
      "name": "Larry Hubbard",
      "affiliations": []
    },
    {
      "last_name": "Esser",
      "fore_name": "Barbara A",
      "initials": "BA",
      "name": "Barbara A Esser",
      "affiliations": []
    },
    {
      "last_name": "Lovato",
      "fore_name": "James F",
      "initials": "JF",
      "name": "James F Lovato",
      "affiliations": []
    },
    {
      "last_name": "Perdue",
      "fore_name": "Letitia H",
      "initials": "LH",
      "name": "Letitia H Perdue",
      "affiliations": []
    },
    {
      "last_name": "Goff",
      "fore_name": "David C",
      "initials": "DC",
      "name": "David C Goff",
      "affiliations": []
    },
    {
      "last_name": "Cushman",
      "fore_name": "William C",
      "initials": "WC",
      "name": "William C Cushman",
      "affiliations": []
    },
    {
      "last_name": "Ginsberg",
      "fore_name": "Henry N",
      "initials": "HN",
      "name": "Henry N Ginsberg",
      "affiliations": []
    },
    {
      "last_name": "Elam",
      "fore_name": "Marshall B",
      "initials": "MB",
      "name": "Marshall B Elam",
      "affiliations": []
    },
    {
      "last_name": "Genuth",
      "fore_name": "Saul",
      "initials": "S",
      "name": "Saul Genuth",
      "affiliations": []
    },
    {
      "last_name": "Gerstein",
      "fore_name": "Hertzel C",
      "initials": "HC",
      "name": "Hertzel C Gerstein",
      "affiliations": []
    },
    {
      "last_name": "Schubart",
      "fore_name": "Ulrich",
      "initials": "U",
      "name": "Ulrich Schubart",
      "affiliations": []
    },
    {
      "last_name": "Fine",
      "fore_name": "Lawrence J",
      "initials": "LJ",
      "name": "Lawrence J Fine",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "The New England journal of medicine",
    "iso_abbreviation": "N Engl J Med",
    "issn": "1533-4406",
    "issn_type": "Electronic",
    "volume": "363",
    "issue": "3",
    "pub_year": "2010",
    "pub_month": "Jul",
    "pub_day": "15"
  },
  "start_page": "233",
  "end_page": "244",
  "pages": "233-44",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Multicenter Study",
    "Randomized Controlled Trial",
    "Research Support, N.I.H., Extramural"
  ],
  "keywords": [
    "Antihypertensive Agents",
    "Cardiovascular Diseases",
    "Cholesterol, LDL",
    "Diabetes Mellitus, Type 2",
    "Diabetic Retinopathy",
    "Disease Progression",
    "Drug Therapy, Combination",
    "Dyslipidemias",
    "Female",
    "Fenofibrate",
    "Follow-Up Studies",
    "Glycated Hemoglobin",
    "Humans",
    "Hyperglycemia",
    "Hypertension",
    "Hypoglycemic Agents",
    "Hypolipidemic Agents",
    "Male",
    "Middle Aged",
    "Simvastatin"
  ],
  "article_ids": {
    "pubmed": "20587587",
    "mid": "NIHMS222645",
    "pmc": "PMC4026164",
    "doi": "10.1056/NEJMoa1001288",
    "pii": "NEJMoa1001288"
  },
  "doi": "10.1056/NEJMoa1001288",
  "pmc_id": "PMC4026164",
  "dates": {
    "completed": "2010-07-29",
    "revised": "2025-05-29"
  },
  "chemicals": [
    "Antihypertensive Agents",
    "Cholesterol, LDL",
    "Glycated Hemoglobin A",
    "Hypoglycemic Agents",
    "Hypolipidemic Agents",
    "Simvastatin",
    "Fenofibrate"
  ],
  "grants": [
    {
      "grant_id": "N01 HC095179",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095184",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095178",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "Z99 EY999999",
      "agency": "Intramural NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95180",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095178",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "IAA-Y1-HC-1010",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095182",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95183",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95178",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95179",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95181",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "ZIA EY000410",
      "agency": "Intramural NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "IAA-Y1-HC-9035",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095180",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "Y01 HC001010",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "Y01 HC009035",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095181",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95184",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "R01 HL073030",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01-HC-95182",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    },
    {
      "grant_id": "N01 HC095183",
      "agency": "NHLBI NIH HHS",
      "country": "United States"
    }
  ],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T14:22:38.269723",
    "pmid": "20587587"
  }
}